We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$303M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.2M
3
IYR icon
iShares US Real Estate ETF
IYR
+$17.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.4M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$26.8M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.6M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$24.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$24M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.2M

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTK
3401
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
100
-1,472
-94% -$19.5K
YVR
3402
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$1K ﹤0.01%
17
– –
NMTR
3403
DELISTED
9 Meters Biopharma
NMTR
$1K ﹤0.01%
+4
New +$2.21K
BNSO
3404
DELISTED
Bonso Electronic International
BNSO
$1K ﹤0.01%
300
-100
-25% -$180
AGRX
3405
DELISTED
Agile Therapeutics
AGRX
– –
0
– –
SMIT
3406
DELISTED
Schmitt Industries Inc
SMIT
$1K ﹤0.01%
789
– –
STAB
3407
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$1K ﹤0.01%
+599
New +$1.32K
HTGM
3408
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1K ﹤0.01%
2
-1
-33% -$447
AMPE
3409
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1K ﹤0.01%
4
-20
-83% -$5.61K
SMED
3410
DELISTED
Sharps Compliance Corp
SMED
$1K ﹤0.01%
294
-1,248
-81% -$6.05K
GPL
3411
DELISTED
Great Panther Mining Limited
GPL
$1K ﹤0.01%
+80
New +$1.12K
NP
3412
DELISTED
Neenah, Inc. Common Stock
NP
$1K ﹤0.01%
14
-1,265
-99% -$97.1K
PTE
3413
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1K ﹤0.01%
+16
New +$1.57K
ZSAN
3414
DELISTED
Zosano Pharma Corporation
ZSAN
$1K ﹤0.01%
1
-1
-50% -$797
NUAN
3415
DELISTED
Nuance Communications, Inc.
NUAN
$1K ﹤0.01%
69
-165
-71% -$2.16K
SBM
3416
DELISTED
ProShares Short Basic Materials
SBM
$1K ﹤0.01%
+5
New +$594
ESXB
3417
DELISTED
Community Bankers Trust Corporation
ESXB
$1K ﹤0.01%
+127
New +$672
INOV
3418
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$1K ﹤0.01%
100
-300
-75% -$4.98K
KDMN
3419
DELISTED
Kadmon Holdings, Inc.
KDMN
$1K ﹤0.01%
+140
New +$1.28K
NNA
3420
DELISTED
Navios Maritime Acquisition Corporation
NNA
$1K ﹤0.01%
+31
New +$685
JAX
3421
DELISTED
J. Alexander's Holdings, Inc.
JAX
$1K ﹤0.01%
+55
New +$540
SHSP
3422
DELISTED
SharpSpring, Inc.
SHSP
$1K ﹤0.01%
182
-208
-53% -$1.08K
AMRB
3423
DELISTED
American River Bankshares
AMRB
$1K ﹤0.01%
107
+7
+7% +$73
HCAP
3424
DELISTED
Harvest Capital Credit Corporation
HCAP
$1K ﹤0.01%
54
-958
-95% -$12.1K
NBRV
3425
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
0
– –
135 136
137
138 139

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.